<DOC>
	<DOCNO>NCT00178919</DOCNO>
	<brief_summary>The amount blood flow different part body regulate autonomic ( automatic ) nerve local factor produce blood vessel . Nitric oxide ( NO ) one important metabolic factor . If production NO slow stop amount blood different part body decrease . There increase knowledge NO mechanism impair number medical condition . NO function reduce patient risk factor atherosclerosis ( harden artery ) hypercholesterolemia ( patient high cholesterol ) , diabetes mellitus , also impaired smoker . This NO `` deficiency '' believe contribute great cardiovascular risk mark patient population . This study design examine endothelial nitric oxide important control mechanism blood pressure normal condition , impairment nitric oxide contribute hypertension .</brief_summary>
	<brief_title>Nitric Oxide Autonomic Nervous System</brief_title>
	<detailed_description />
	<mesh_term>Pure Autonomic Failure</mesh_term>
	<mesh_term>Trimethaphan</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<mesh_term>Trimethaphan camsylate</mesh_term>
	<mesh_term>omega-N-Methylarginine</mesh_term>
	<criteria>Adult subject . 18 85 year . Nonsmokers long term smoker specific aim 6 . Drugfree . Long term hypertension specific substudy 3 , patient autonomic failure specific aim 4 5 , diabetes mellitus specific aim 5 . Being medication antihypertensive ( hypertensive ) , autonomic medication ( autonomic failure [ AF ] patient ) , insulin treatment diabetes ( diabetic patient ) . Having pulmonary , renal , hematopoietic , hepatic and/or cardiac disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Endothelial Nitric Oxide</keyword>
	<keyword>L-NMMA</keyword>
	<keyword>Trimethaphan</keyword>
	<keyword>Autonomic Nervous System</keyword>
	<keyword>Nitric Oxide Inhibition</keyword>
</DOC>